FDA Inspection 699568 — Osteotech, Inc.

Osteotech, Inc. — FEI 3002277646

The FDA completed an inspection of Osteotech, Inc. on Dec 9, 2010 in Shrewsbury, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 9, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Shrewsbury, NJ (United States)

Citations

IDCFRDescription
1233721 CFR 1271.180(a)Design adequate to bar spread of CD's
1242121 CFR 1271.265(a)Acceptance criteria designed to prevent CD

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.